Prevention of insulin resistance and beta‐cell loss by abrogating PKCε‐induced serine phosphorylation of muscle IRS‐1 in Psammomys obesus

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Diabetes/Metabolism Research Reviews

• Publication date

  2008-10-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1002/dmrr.881PMID 18613220
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Gradual loss of pancreatic beta-cell insulin, glucokinase and GLUT2 glucose transporter immunoreactivities during the time course of nutritionally induced type-2 diabetes in Psammomys obesus (sand rat)

  2014cited by this paper
• Phosphorylation of Irs1 at SER-522 inhibits insulin signaling.

  2007cited by this paper
• Inhibition of PKCepsilon improves glucose-stimulated insulin secretion and reduces insulin clearance.

  2007cited by this paper
• C-reactive protein induces phosphorylation of insulin receptor substrate-1 on Ser307 and Ser612 in L6 myocytes, thereby impairing the insulin signalling pathway that promotes glucose transport

  2007cited by this paper
• Insight into intra- and inter-molecular interactions of PKC: design of specific modulators of kinase function.

  2007cited by this paper
• Inhibition of PKCɛ Improves Glucose-Stimulated Insulin Secretion and Reduces Insulin Clearance

  2007cited by this paper
• Leptin down‐regulates insulin action through phosphorylation of serine‐318 in insulin receptor substrate 1

  2006cited by this paper
• Antidiabetic effect of novel modulating peptides of G-protein-coupled kinase in experimental models of diabetes

  2004cited by this paper
• Sequence-based Design of Kinase Inhibitors Applicable for Therapeutics and Target Identification*

  2004cited by this paper
• Cellular mechanism of nutritionally induced insulin resistance in Psammomys obesus: overexpression of protein kinase Cepsilon in skeletal muscle precedes the onset of hyperinsulinemia and hyperglycemia.

  2001cited by this paper
• Insulin/IGF-1 and TNF-alpha stimulate phosphorylation of IRS-1 at inhibitory Ser307 via distinct pathways.

  2001cited by this paper
• - Cell Glucotoxicity in the Psammomys obesus Model of Type 2 Diabetes

  2001cited by this paper
• beta-cell glucotoxicity in the Psammomys obesus model of type 2 diabetes.

  2001cited by this paper
• Serine residues 994 and 1023/25 are important for insulin receptor kinase inhibition by protein kinase C isoforms β2 and θ

  2000cited by this paper
• Serine residues 994 and 1023/25 are important for insulin receptor kinase inhibition by protein kinase C isoforms beta2 and theta.

  2000cited by this paper
• Nutritionally Induced Insulin Resistance and Receptor Defect Leading to β‐Cell Failure in Animal Models

  1999cited by this paper
• Hyperglycemia-induced beta-cell apoptosis in pancreatic islets of Psammomys obesus during development of diabetes.

  1999cited by this paper
• Irreversibility of nutritionally induced NIDDM in Psammomys obesus is related to beta-cell apoptosis.

  1999cited by this paper
• Protein kinase C modulation of insulin receptor substrate-1 tyrosine phosphorylation requires serine 612.

  1997cited by this paper
• Hyperinsulinemia induces a reversible impairment in insulin receptor function leading to diabetes in the sand rat model of non-insulin-dependent diabetes mellitus.

  1994cited by this paper
• PSAMMOMYS OBESUS OF THE JERUSALEM COLONY: A MODEL FOR NUTRITIONALLY INDUCED, NON-INSULIN-DEPENDENT DIABETES

  1993cited by this paper
• Characterization of Stages in Development of Obesity-Diabetes Syndrome in Sand Rat (Psammomys obesus)

  1986cited by this paper
• Diabetes mellitus: a "thrifty" genotype rendered detrimental by "progress"?

  1962cited by this paper

• Diverting hepatic lipid fluxes with lifestyles revision and pharmacological interventions as a strategy to tackle steatotic liver disease (SLD) and hepatocellular carcinoma (HCC)

  2024cites this paper
• Obesity-Related Insulin Resistance: The Central Role of Adipose Tissue Dysfunction.

  2022cites this paper
• Inhibition of Viral Membrane Fusion by Peptides and Approaches to Peptide Design

  2021cites this paper
• Diacylglycerol-evoked activation of PKC and PKD isoforms in regulation of glucose and lipid metabolism: a review

  2020cites this paper
• Anti-oxidant, anti-apoptotic, anti-hypoxic and anti-inflammatory conditions induced by PTY-2 against STZ-induced stress in islets

  2019cites this paper
• Do flavanols-rich natural products relieve obesity-related insulin resistance?

  2018cites this paper
• Epigenetic programming, early life nutrition and the risk of metabolic disease.

  2017cites this paper
• Steroidogenic acute regulatory protein (StAR) overexpression attenuates HFD-induced hepatic steatosis and insulin resistance.

  2017cites this paper
• Epigenetics and metabolic disease

  2017cites this paper
• Modulation of skeletal muscle insulin sensitivity and SNAT2 amino acid transporter expression by fatty acid availability

  2015cites this paper
• Rôle de la vasopressine dans les troubles du métabolisme glucidique : possible impact dans le développement du diabète

  2014cites this paper
• AMPK-derived peptides reduce blood glucose levels but lead to fat retention in the liver of obese mice.

  2014cites this paper
• A polyphenol rescues lipid induced insulin resistance in skeletal muscle cells and adipocytes.

  2014cites this paper
• Insulin receptor signaling in normal and insulin-resistant states.

  2014cites this paper
• Fatty acids, monocytes and ageing

  2013cites this paper
• Regulation of insulin sensitivity by serine/threonine phosphorylation of insulin receptor substrate proteins IRS1 and IRS2

  2012cites this paper
• Mechanism of Lipid Induced Insulin Resistance: An Overview

  2012cites this paper
• Chapter 54 – Sand Rat

  2012cites this paper
• The use of animal models in diabetes research

  2012cites this paper
• Mechanism of lipid induced insulin resistance: activated PKCε is a key regulator.

  2011cites this paper
• Deciphering the Arginine-Binding Preferences at the Substrate-Binding Groove of Ser/Thr Kinases by Computational Surface Mapping

  2011cites this paper
• Identification of a small molecule activator of novel PKCs for promoting glucose-dependent insulin secretion

  2011cites this paper
• Palmitate-Activated Macrophages Confer Insulin Resistance to Muscle Cells by a Mechanism Involving Protein Kinase C θ and ε

  2011cites this paper
• Rodent Models of Diabetes and Diabetes Complications

  2011cites this paper
• Protein kinase C isoforms: Mediators of reactive lipid metabolites in the development of insulin resistance

  2011cites this paper
• The development of activating and inhibiting camelid VHH domains against human protein kinase C epsilon.

  2011cites this paper
• Molecular Dynamics Simulations and Elastic Network Analysis of Protein Kinase B (Akt/PKB) Inactivation

  2010cites this paper
• Contribution of animal models to the research of the causes of diabetes.

  2010cites this paper
• BlockMaster: partitioning protein kinase structures using normal-mode analysis.

  2009cites this paper
• Rational redesign of neutral endopeptidase binding to merlin and moesin proteins

  2009cites this paper
• Peptide inhibitors targeting protein kinases.

  2009cites this paper
• A useful list of spontaneously arising animal models of obesity and diabetes.

  2009cites this paper
• Deletion of PKCε Selectively Enhances the Amplifying Pathways of Glucose-Stimulated Insulin Secretion via Increased Lipolysis in Mouse β-Cells

  2009cites this paper
• Sp1 Phosphorylation and Its Regulation of Gene Transcription

  2009cites this paper
• Current literature in diabetes

  2009cites this paper
• PKC delta and epsilon in drug targeting and therapeutics.

  2009influential citation
• Selenium and diabetes: an enigma?

  2009cites this paper
• Peptidic modulators of protein‐protein interactions: Progress and challenges in computational design

  2009cites this paper